Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hepatitis

  Free Subscription


Articles published in Arch Virol

Retrieve available abstracts of 24 articles:
HTML format



Single Articles


    October 2022
  1. HUAREZ B, Hernandez-Vasquez A, Azanedo D, Vargas-Fernandez R, et al
    Prevalence of hepatitis C virus infection in patients with end-stage renal disease in Latin America and the Caribbean: a systematic review and meta-analysis.
    Arch Virol. 2022 Oct 5. pii: 10.1007/s00705-022-05604.
    PubMed     Abstract available


    September 2022
  2. ABD-ELSALAM S, Sharaf-Eldin M, Soliman S, Elfert A, et al
    Retraction Note to: Efficacy and safety of sofosbuvir plus ribavirin for treatment of cirrhotic patients with genotype 4 hepatitis C virus in real-life clinical practice.
    Arch Virol. 2022 Sep 20. pii: 10.1007/s00705-022-05600.
    PubMed    


  3. CANCELA F, Noceti O, Arbiza J, Mirazo S, et al
    Structural aspects of hepatitis E virus.
    Arch Virol. 2022 Sep 13. pii: 10.1007/s00705-022-05575.
    PubMed     Abstract available


    May 2022
  4. BOGLIONE L, De Benedetto I, Dodaro V, Chiecchio M, et al
    Role of plasmatic and urinary concentration of tenofovir disoproxil fumarate in a cohort of patients affected by chronic hepatitis B.
    Arch Virol. 2022 May 22. pii: 10.1007/s00705-022-05466.
    PubMed     Abstract available


    March 2022
  5. QU C, Li Y, Li Y, Pan Y, et al
    Full-length MAVS, a mitochondrial antiviral-signaling protein, inhibits hepatitis E virus replication, requiring JAK-STAT signaling.
    Arch Virol. 2022 Mar 24. pii: 10.1007/s00705-022-05415.
    PubMed     Abstract available


    February 2022
  6. SALARI N, Darvishi N, Hemmati M, Shohaimi S, et al
    Global prevalence of hepatitis C in prisoners: a comprehensive systematic review and meta-analysis.
    Arch Virol. 2022 Feb 14. pii: 10.1007/s00705-022-05382.
    PubMed     Abstract available


    January 2022
  7. MESHRAM RJ, Kathwate GH, Gacche RN
    Progress, evolving therapeutic/diagnostic approaches, and challenges in the management of hepatitis C virus infections.
    Arch Virol. 2022 Jan 28. pii: 10.1007/s00705-022-05375.
    PubMed     Abstract available


  8. WOLF JM, Mazeto TK, Pereira VRZB, Simon D, et al
    Recent molecular evolution of hepatitis B virus genotype F in Latin America.
    Arch Virol. 2022 Jan 25. pii: 10.1007/s00705-022-05376.
    PubMed     Abstract available


  9. XU R, Wang H, Huang J, Wang M, et al
    Complete genome sequencing and evolutionary analysis of hepatitis C virus subtype 6a, including strains from Guangdong Province, China.
    Arch Virol. 2022 Jan 20. pii: 10.1007/s00705-021-05358.
    PubMed     Abstract available


    November 2021
  10. SILVA LA, Camargo BR, Araujo AC, Batista TL, et al
    Easily purified baculovirus/insect-system-expressed recombinant hepatitis B virus surface antigen fused to the N- or C-terminus of polyhedrin.
    Arch Virol. 2021 Nov 28. pii: 10.1007/s00705-021-05305.
    PubMed     Abstract available


  11. OKSUZ Z, Ucbilek E, Serin MS, Yaras S, et al
    Possible relationship between IL28B rs12979860 and TLR2 -196 to -174 del/ins polymorphisms and the liver fibrosis stage in hepatitis C patients.
    Arch Virol. 2021 Nov 24. pii: 10.1007/s00705-021-05302.
    PubMed     Abstract available


  12. LIU J, Wang Z, Tang J, Tang R, et al
    Correction to: Hepatitis C virus core protein activates Wnt/beta-catenin signaling through multiple regulation of upstream molecules in the SMMC-7721 cell line.
    Arch Virol. 2021 Nov 4. pii: 10.1007/s00705-021-05275.
    PubMed    


  13. CHEN Y, Cai S, Zhang Y, Lai Z, et al
    First identification and genomic characterization of equine hepacivirus subtype 2 in China.
    Arch Virol. 2021;166:3221-3224.
    PubMed     Abstract available


    September 2021
  14. SHEN H, Liu S, Ding M, Gu H, et al
    A quadruple recombination event discovered in hepatitis E virus.
    Arch Virol. 2021 Sep 24. pii: 10.1007/s00705-021-05251.
    PubMed     Abstract available


  15. CHEN Z, Shi SH, Huang Y, Huang CQ, et al
    Differential metabolism-associated gene expression of duck pancreatic cells in response to two strains of duck hepatitis A virus type 1.
    Arch Virol. 2021 Sep 5. pii: 10.1007/s00705-021-05199.
    PubMed     Abstract available


  16. OLAGBENRO M, Anderson M, Gaseitsiwe S, Powell EA, et al
    In silico analysis of mutations associated with occult hepatitis B virus (HBV) infection in South Africa.
    Arch Virol. 2021 Sep 1. pii: 10.1007/s00705-021-05196.
    PubMed     Abstract available


    August 2021
  17. RAO JR, Rafique S, Ali A, Rehman G, et al
    Next-generation sequencing studies on the E1-HVR1 region of hepatitis C virus (HCV) from non-high-risk HCV patients living in Punjab and Khyber Pakhtunkhwa, Pakistan.
    Arch Virol. 2021 Aug 27. pii: 10.1007/s00705-021-05203.
    PubMed     Abstract available


    July 2021
  18. NASIMZADEH S, Azaran A, Jalilian S, Makvandi M, et al
    Prevalence of occult hepatitis C virus infection in beta-thalassemia major patients in Ahvaz, Iran.
    Arch Virol. 2021 Jul 18. pii: 10.1007/s00705-021-05126.
    PubMed     Abstract available


  19. MIRI HH, Fazeli P, Ali-Hassanzadeh M, Bemani P, et al
    Correlation between IL-28 polymorphism and spontaneous clearance in HCV patients: systematic review and meta-analysis.
    Arch Virol. 2021 Jul 3. pii: 10.1007/s00705-021-05141.
    PubMed     Abstract available


    June 2021
  20. PORTILHO MM, Bezerra CS, Mendonca ACDF, Marques VA, et al
    Applicability of oral fluid samples for tracking hepatitis B virus mutations, genotyping, and phylogenetic analysis.
    Arch Virol. 2021 Jun 19. pii: 10.1007/s00705-021-05122.
    PubMed     Abstract available


    May 2021
  21. LI Y, Miao Z, Li P, Zhang R, et al
    Ivermectin effectively inhibits hepatitis E virus replication, requiring the host nuclear transport protein importin alpha1.
    Arch Virol. 2021 May 14. pii: 10.1007/s00705-021-05096.
    PubMed     Abstract available


  22. DE PINA-ARAUJO IIM, Horta MA, do Amaral Mello FC, Soares CC, et al
    Human pegivirus 1 in Cabo Verde: prevalence and genotypic distribution among HIV-infected individuals.
    Arch Virol. 2021;166:1345-1353.
    PubMed     Abstract available


    April 2021
  23. LI MH, Lu Y, Sun FF, Chen QQ, et al
    Transforming growth factor beta as a possible independent factor in chronic hepatitis B.
    Arch Virol. 2021 Apr 19. pii: 10.1007/s00705-021-05062.
    PubMed     Abstract available


  24. ALI NA, Hamdy NM, Gibriel AA, El Mesallamy HO, et al
    Investigation of the relationship between CTLA4 and the tumor suppressor RASSF1A and the possible mediating role of STAT4 in a cohort of Egyptian patients infected with hepatitis C virus with and without hepatocellular carcinoma.
    Arch Virol. 2021 Apr 1. pii: 10.1007/s00705-021-04981.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: